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Aim of database: The Danish Nonmelanoma Skin Cancer Dermatology Database was 
established in 2008. The aim of this database was to collect data on nonmelanoma skin cancer 
(NMSC) treatment and improve its treatment in Denmark. NMSC is the most common malig-
nancy in the western countries and represents a significant challenge in terms of public health 
management and health care costs. However, high-quality epidemiological and treatment data 
on NMSC are sparse.
Study population: The NMSC database includes patients with the following skin tumors: 
basal cell carcinoma (BCC), squamous cell carcinoma, Bowen’s disease, and keratoacanthoma 
diagnosed by the participating office-based dermatologists in Denmark.
Main variables: Clinical and histological diagnoses, BCC subtype, localization, size, skin 
cancer history, skin phototype, and evidence of metastases and treatment modality are the main 
variables in the NMSC database. Information on recurrence, cosmetic results, and complications 
are registered at two follow-up visits at 3 months (between 0 and 6 months) and 12 months 
(between 6 and 15 months) after treatment.
Descriptive data: In 2014, 11,522 patients with 17,575 tumors were registered in the database. 
Of tumors with a histological diagnosis, 13,571 were BCCs, 840 squamous cell carcinomas, 
504 Bowen’s disease, and 173 keratoakanthomas.
Conclusion: The NMSC database encompasses detailed information on the type of tumor, 
a variety of prognostic factors, treatment modalities, and outcomes after treatment. The database 
has revealed that overall, the quality of care of NMSC in Danish dermatological clinics is high, 
and the database provides the necessary data for continuous quality assurance.
Keywords: nonmelanoma skin cancer, basal cell carcinoma, squamous cell carcinoma, 
 epidemiology, treatment
Aim of database
The Danish Nonmelanoma Skin Cancer Dermatology Database is a publicly funded 
national clinical database. It was established in 2008 to monitor the quality of treatment 
for nonmelanoma skin cancer (NMSC) by dermatologists in office-based settings and 
provide the necessary data for quality assurance and improvement.
The concept of NMSC primarily refers to basal cell carcinoma (BCC) and squamous 
cell carcinoma (SCC). These tumors are the most common malignancies in Denmark 
as well as in other Western countries.1,2 In spite of its low mortality, the high prevalence 
of NMSC makes it a significant challenge in terms of health management and health 
care costs.3 Care for NMSC is complex, with treatments provided in both hospitals and 
office-based settings. Several medical specialties may be involved in the treatment of 
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NMSC, but the primary care providers are dermatologists, 
often within an office-based setting.3,4
A wide range of different treatments are used in the man-
agement of NMSC, eg, Mohs micrographic surgery, excision, 
cryotherapy, curettage, curettage combined with cautery, 
cryotherapy or laser, photodynamic therapy, radiotherapy, 
and imiquimod. Guidelines have been published by several 
organizations.5–8
The cost of treatment depends on treatment modality and 
setting (hospital or office based).3 However, little is known 
about the effectiveness of the most commonly used treatment 
modalities for SCC and BCC.7–10 The current knowledge 
comes predominantly from selected patient groups in studies 
often performed in single hospital centers.7–10 The management 
of NMSC differs between countries, and compared to other 
countries, curettage is used more frequently in Denmark10 and 
Mohs micrographic surgery is less often performed.
Detailed data on NMSC and its treatment in routine 
clinical practice are important for surveillance, assessment 
of prognosis, quality assurance, and improvements.2,11,12 Such 
data can only be obtained from clinical databases, which are 
an attractive resource for epidemiological research.11,12
The NMSC database contains detailed data on NMSC 
diagnosed by the participating dermatologists, providing the 
necessary data for quality assurance and improvement. The 
aim of the NMSC database is to collect data on NMSC treat-
ment and improve the treatment of NMSC in Denmark.
Study population
The NMSC database includes patients with the skin tumors 
BCC, SCC, Bowen’s disease, and keratoacanthoma diag-
nosed by the participating office-based dermatologists in 
Denmark.
Between January 2008 and January 2011, the NMSC 
database was a regional database, incorporating data on 
NMSC patients diagnosed and treated at dermatology clinics 
in the Central and North Denmark Regions, which have a 
combined population of 1.8 million people that accounts for 
∼30% of the Danish population. After approval by the Danish 
National Board of Health, the database started operating at a 
national (5.6 million people) level since February 2011.
Collecting prospective data highly increases the workload 
of the registering clinics. In 2014, 11,522 patients with 17,575 
tumors were registered in the database, and .72,000 tumors 
are now registered in the database.
Completeness can be difficult to estimate precisely, 
because not all cases are sent for histopathology or registered 
in other registries. However, using the Danish Pathology 
Registry as a gold standard, the overall data completeness is 
62%. Some clinics do not register. The completeness of the 
clinics registering in the database is 75%. The completeness 
of the individual variables is high, with only a few (median 
2%) missing data (Table 1).
A new online registration system is under construction. 
This system will have a special data capture technique, 
enabling an NMSC database reminder when an NMSC 
patient is in the clinic. Higher completeness will make the 
database a strong research tool. Extra efforts will be taken to 
enroll the clinics not registering in the database.
Main variables
Content of the NMSC database
The NMSC database operates via an Internet-based online 
registration system. A common interface form ensures stan-
dardized data collection. Data are entered into a computer-
based data management system using the civil personal 
registry number (a unique ten-digit number assigned to each 
Danish citizen at birth or immigration).
For each patient, the treating dermatologist enters detailed 
information on tumor, treatment, and evaluation after treat-
ment. The exact localization of the tumor is marked on an 
anatomical position sketch.
On the day of treatment, the treating dermatologist com-
pletes a questionnaire with detailed information on prognostic 
and treatment-related variables: clinical and histological diag-
noses, clinical BCC subtype, localization, size, skin cancer 
history, skin phototype, evidence of metastases, and treatment 
Table 1 Main variables in the Danish Nonmelanoma Skin Cancer 
Dermatology Database
Data quality,  
PPV% (95% CI)
Missing  
data (%)
Clinical diagnosis – 0.4
Histological examination – 5
Histological diagnosis 100 (95–100) 5
Localization 96 (89–99) 0
Size 85 (69–95) 6
Skin cancer history 97 (85–100) –
Skin phototype – –
Evidence of metastases – 0
Treatment modality 95 (87–99) –
Recurrence 100 (29–100) –
Cosmetic result (physician) – 2
Cosmetic result (patient) – 11
Complications 100 (16–100) 1
Notes: PPv was not examined for variables not routinely registered in the medical 
records. Missing data are not calculated for all variables in the annual report and are 
missing in the table. – represents no data available. Republished with permission of 
Dove Medical Press, from Registration in the Danish Regional Nonmelanoma Skin 
Cancer Dermatology Database: completeness of registration and accuracy of key 
variables, Lamberg AL, Cronin-Fenton D, Olesen AB, Clin Epidemiol, 2010;2:123–136,13 
Copyright ©2010; permission conveyed through Copyright Clearance Center, inc.
Abbreviations: PPV, positive predictive value; CI, confidence interval.
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modality. The histology report is added when it is received. 
If the patients have new tumors or recurrences later in life, 
these are added to the anatomical position sketch.
Data quality
We have previously examined the accuracy of the registrations 
in the NMSC database using medical record review as a gold 
standard. However, for the variable “histological diagnosis,” the 
Danish Pathology Registry was used as a gold standard.13
Overall, the accuracy of variables registered in the NMSC 
database was high.13 Positive predictive value (PPV) of histo-
logically verified diagnoses was 100% using the Danish 
Pathology Registry as a gold standard. The PPV was 96% for 
localization, 85% for size, and 91% for the date of treatment. The 
PPV of treatment modality registered was 95%13 (Table 1).
Treatment quality
In order to monitor and facilitate improvement of treatment, 
six quality indicators have been chosen related to diagno-
sis, surveillance, and outcome of the treatment of NMSC, 
Bowen’s disease, and keratoacanthoma (Table 2).
A report is published annually with data from the database 
showing data on all six quality indicators, with comments 
from both an epidemiologist and the steering committee of 
the NMSC database.
Follow-up
NMSC patients are scheduled for two follow-up visits, one at 
∼3 months (between 0 and 6 months) and one at ∼12 months 
(between 6 and 15 months) after  treatment. At these visits, 
information on recurrence,  cosmetic result, and complica-
tions are entered in the database.
In 2014, 54% of the patients were registered in the 
database at the first follow-up visit and 38% at the second 
follow-up visit.
Examples of research
The database was developed as a part of a PhD study.14 A vali-
dation study was conducted as a part of the PhD study.13
Data in the NMSC database are available for clinical 
research. It is possible to apply for data at the Danish  Clinical 
Registries. The dermatologists registering in the database also 
have to apply for data for clinical research.
Using the civil personal registry number, data on patients 
can be linked to other Danish medical and population-based 
databases. The Civil Registration System stores information 
from 1968 to present, including date of birth, change of 
address, date of emigration, and exact date of death.15
Currently, three studies are in process:
1. regional variations in the treatment of NMSC;
2. recurrence rate after treatment of NMSC in Denmark; 
and
3. characteristics and treatments of keratoacanthoma.
The management of NMSC differs not only between 
countries but also nationally. Study 1 describes the regional 
differences in the management of treatment. A wide range 
of treatments can be used in the treatment of a low-risk 
tumor according to national and international guidelines.5–8 
Study 2 investigates the recurrence rates, providing real-
world data to the understanding of recurrence risk asso-
ciated with the available different treatment modalities 
adjusted for clinical characteristics of the tumors. Study 3 
provides epidemio logical data on keratoacanthomas, 
increasing our understanding of these tumors that resemble 
SCCs clinically and histologically but are self-limiting 
and benign.
Administrative issues and funding
Organization
The NMSC database was initiated in cooperation with the 
Danish Dermatological Society and the Danish Dermatolo-
gists’ Organization in 2007. The organization of the NMSC 
database consists of a steering committee of dermatologists 
from both hospitals and office-based clinics, as well as repre-
sentatives from the Central Denmark Region administration. 
Currently, the steering committee of NMSC database has 
12 members who administer the database.
The development of the database was funded by the 
Danish Regional Collaboration of Specialists “Fonden for 
Faglig Udvikling af Speciallægepraksis” and “Aage Bangs 
Foundation.”
Table 2 Quality indicators in the Danish Nonmelanoma Skin 
Cancer Dermatology Database
Diagnostic Proportion of tumors undergoing histological 
examination
Follow-up Proportion of patients attending follow-up 
visits at 3 months (0–6 months) and 12 months 
(6–15 months)
Recurrence-free  
survival at 3 months
Proportion of tumors without recurrence at 
3 months of follow-up
Recurrence-free  
survival at 15 months
Proportion of tumors without recurrence at 
15 months of follow-up
Complications Proportion of patients without complications 
in relation to treatment
Cosmetic results Proportion of patients with a high score 
of satisfaction with the cosmetic result – 
evaluated by the patient 
Proportion of patients with a high score 
of satisfaction with the cosmetic result – 
evaluated by the treating physician
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The NMSC database is approved as a national clinical 
quality database. Patient privacy is ensured by encryption and 
password protection. The dermatologists only have access 
to their own data.
The Danish Regional Funding for Clinical Databases 
funds the daily operation of the NMSC database. The 
database is operated by DAK-E (Danish Quality Unit of 
General Practice), and in future, DAK-E will fund the daily 
operation.
Conclusion
The NMSC database encompasses detailed information on 
the type of tumor, a variety of prognostic factors, treatment 
 modality, and outcomes after treatment. The main strength 
of the NMSC database is the very detailed registration and 
the high accuracy of the registrations.13 To the best of our 
know ledge, comparable NMSC data have previously been 
registered only in smaller cohorts of patients for limited time 
periods. The value of the Danish NMSC database may prove 
to be even greater than NMSC databases of other countries 
because of the unique opportunity to link it with other Danish 
population-based and medical data sources.
The care of NMSC is multidisciplinary, and a limitation 
of the database is that only dermatology clinics currently 
register in the database. A future goal is to cooperate with 
hospital departments in dermatology, plastic surgery, and 
oncology.
So far the database has revealed that the overall quality of 
care of NMSC in Danish dermatological clinics is high, and 
the database will provide the necessary data for continuous 
quality assurance and improvement.
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